The Securities and Exchange Commission

[thepennyking]

UPDATE - SEC suspends trading in Vaso Active stock
Thursday April 1, 7:21 pm ET


(Adds company comment, changes dateline from WASHINGTON)
NEW YORK, April 1 (Reuters) - U.S. securities regulators on Thursday halted trading of Vaso Active Pharmaceuticals Inc. (NasdaqSC:VAPH - News), a marketer of over-the-counter pharmaceuticals, through April 15.


The Securities and Exchange Commission questioned assertions made by the Danvers, Massachusetts-based company of regarding an FDA approval of certain key products, among other issues.

Vaso Active said in a statement it is "committed to providing the company's full cooperation," but that it would be "inappropriate to provide a more detailed comment at this time."

The SEC said it questioned the accuracy of assertions made in the company's press releases, annual report, registration statement, and public statements to investors.

Vaso shares closed at $7.59 Wednesday on the Nasdaq.

Vaso Active Pharmaceuticals Statement in Response to SEC April 1st Release
Thursday April 1, 7:00 pm ET


DANVERS, Mass.--(BUSINESS WIRE)--April 1, 2004--Vaso Active Pharmaceuticals (NasdaqSC: VAPH) is committed to providing the company's full cooperation in addressing the concerns raised by the Commission in its release issued April 1, 2004. As this matter is in its early stages, it would be inappropriate to provide a more detailed comment at this time.

--------------------------------------------------------------------------------
Contact:
Vaso Active Pharmaceuticals
Matt Carter, 978-750-1991x28
[e-mail]